Thailand Officially Launches Life Sciences Innovation Office
Thailand officially launched TILSNA, a new innovation office to boost the country's biomedical and pharmaceutical industries by connecting researchers, businesses, and investors into a unified ecosystem. Deputy Prime Minister Yasothorn Wong
Deputy Prime Minister and Minister of Higher Education, Science, Research and Innovation Yasothorn Wongsawat officially opened TILSNA (Thailand Life Sciences and Biomedical Innovation Office) at the TILSNA Open Day event titled "The New Era of Thailand's Life Sciences." He expressed strong support for TILSNA's role as a critical strategic mechanism to drive the biomedical, pharmaceutical, and health industries while connecting researchers, industry stakeholders, investors, government agencies, and international networks to work together efficiently and boost Thailand's global competitiveness.
The deputy prime minister outlined seven core policy directives: transforming TILSNA from a mere research funder into an innovation ecosystem builder to commercialize research and develop Thailand's health-sector unicorn; addressing national-level biomedical challenges through TILSNA-led research; promoting startups to overcome the "valley of death"; supporting business scaling; serving as a one-stop service linking medical schools with university hospitals; establishing a National Biobank and large-scale health data platform under strict security standards; and actively driving bioeconomy growth, attracting investment, and building global partnerships.
Yasothorn stated that TILSNA will be crucial in directing Thailand's biomedical industry as an economic driver while improving quality of life for Thai citizens. He emphasized that "sustainable health" means citizens must have good health and quality of life, and called for TILSNA's success in elevating living standards and positioning Thailand as a global market leader in life sciences to drive steady and sustainable economic growth. He praised the day's business-matching activities as evidence that the organization goes beyond funding to build a complete research and entrepreneurship ecosystem, bridging the private sector with other government funding agencies across the ministry.
The deputy prime minister also revealed why Thailand must urgently boost its life sciences competitiveness: Thailand possesses strong foundational costs and resources, including a robust public health system, clinical trial infrastructure, and abundant human capital of skilled scientists and physicians. Additionally, Thailand has exceptionally high biodiversity that can be developed into medical devices, pharmaceuticals, and herbal products to attract new investment flows. Promoting Thailand as a clinical research hub will draw major pharmaceutical companies and global expertise while attracting international talent.
